| Size & multiples | |||
| Market Cap | €1.19B | Enterprise Value | €2.72B |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 0.23× | P/FCF | — |
| EV/EBITDA | 4.48× | EV/EBIT | 15.72× |
| EV/Sales | 0.52× | EV/FCF | — |
| FCF Yield | — | Buyback Yield | — |
| Owner Earnings Yield | — | Shareholder Yield | — |
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.16 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 4.79% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows latest annual · EPS TTM -€0.49 · revenue TTM €5.24B · FCF TTM — (in EUR)
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on EV/EBITDA
EV/EBITDA 5th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| EV/EBITDA | 4.5x | 15.2x | 9.9x–24.7x | 5 ↓cheap |
| Dividend Yield | 1.2% | 1.1% | 0.2%–2.4% | 54 ↑strong |
| Net Margin | -1.0% | -21.2% | -325.3%–7.2% | 64 ↑strong |
| Operating Margin | 3.3% | -34.5% | -552.0%–8.0% | 69 ↑strong |
| ROE | -4.6% | -36.8% | -92.5%–4.5% | 69 ↑strong |
